The beneficial effects of renin–angiotensin system inhibitors (RASI) on IgA nephropathy with tubulointerstitial lesions categorized by Oxford classification

被引：0
|
作者：
Takahiro Kamiyama
Takahito Moriyama
Saeko Kumon
Kazunori Karasawa
Kosaku Nitta
机构：
[1] Tokyo Women’s Medical University,Department of Medicine, Kidney Center
来源：
Clinical and Experimental Nephrology | 2019年 / 23卷
关键词：
Immunoglobulin A nephropathy; Renin angiotensin system Inhibitors; Oxford classification; Tubulointerstital lesions; Renal outcome;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：834 / 840
页数：6
相关论文
共 50 条
  • [1] The beneficial effects of renin-angiotensin system inhibitors (RASI) on IgA nephropathy with tubulointerstitial lesions categorized by Oxford classification
    Kamiyama, Takahiro
    Moriyama, Takahito
    Kumon, Saeko
    Karasawa, Kazunori
    Nitta, Kosaku
    CLINICAL AND EXPERIMENTAL NEPHROLOGY, 2019, 23 (06) : 834 - 840
  • [2] The Beneficial Effects of Renin-Angiotensin System Inhibitors on IgA Nephropathy with Global Sclerosis
    Kasama, Eri
    Moriyama, Takahito
    Miyabe, Yoei
    Akiyama, Kenichi
    Karasawa, Kazunori
    Nitta, Kosaku
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2021, 32 (10): : 510 - 510
  • [3] Effects of Combination Therapy with Renin-Angiotensin System Inhibitors and Eicosapentaenoic Acid on IgA Nephropathy
    Moriyama, Takahito
    Iwasaki, Chihiro
    Tanaka, Kayu
    Ochi, Ayami
    Shimizu, Ari
    Shiohira, Syunji
    Itabashi, Mitsuyo
    Takei, Takashi
    Uchida, Keiko
    Tsuchiya, Ken
    Nitta, Kosaku
    INTERNAL MEDICINE, 2013, 52 (02) : 193 - 199
  • [4] Expression of the intrarenal angiotensin receptor and the role of renin-angiotensin system inhibitors in IgA nephropathy
    Zhang, Zheng
    Jiang, Shi-min
    Ma, Ye-ping
    Dai, Pei-lin
    Wang, Yi-ning
    Zou, Gu-ming
    Gao, Hong-mei
    Yang, Yue
    Li, Wen-ge
    MOLECULAR AND CELLULAR BIOCHEMISTRY, 2019, 453 (1-2) : 103 - 110
  • [5] Expression of the intrarenal angiotensin receptor and the role of renin-angiotensin system inhibitors in IgA nephropathy
    Zheng Zhang
    Shi-min Jiang
    Ye-ping Ma
    Pei-lin Dai
    Yi-ning Wang
    Gu-ming Zou
    Hong-mei Gao
    Yue Yang
    Wen-ge Li
    Molecular and Cellular Biochemistry, 2019, 453 : 103 - 110
  • [6] Tonsillectomy reduces recurrence of IgA nephropathy in mesangial hypercellularity type categorized by the Oxford classification
    Keita Hirano
    Hoichi Amano
    Tetsuya Kawamura
    Kyoko Watanabe
    Kentaro Koike
    Akihiro Shimizu
    Satoshi Endo
    Nobuo Tsuboi
    Hideo Okonogi
    Yoichi Miyazaki
    Masato Ikeda
    Kazushige Hanaoka
    Makoto Ogura
    Satoru Komatsumoto
    Takashi Yokoo
    Clinical and Experimental Nephrology, 2016, 20 : 425 - 432
  • [7] Tonsillectomy reduces recurrence of IgA nephropathy in mesangial hypercellularity type categorized by the Oxford classification
    Hirano, Keita
    Amano, Hoichi
    Kawamura, Tetsuya
    Watanabe, Kyoko
    Koike, Kentaro
    Shimizu, Akihiro
    Endo, Satoshi
    Tsuboi, Nobuo
    Okonogi, Hideo
    Miyazaki, Yoichi
    Ikeda, Masato
    Hanaoka, Kazushige
    Ogura, Makoto
    Komatsumoto, Satoru
    Yokoo, Takashi
    CLINICAL AND EXPERIMENTAL NEPHROLOGY, 2016, 20 (03) : 425 - 432
  • [8] IgA nephropathy and inhibitors of the renin angiotensin system: Is reduction in proteinuria adequate proof of efficacy?
    Reddan, DN
    Owen, WF
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2001, 38 (01) : 182 - 185
  • [9] Severity of Arterial and Arteriolar Sclerosis in IgA Nephropathy and Effects of Renin-Angiotensin System Inhibitors on Its Prognosis
    Sugiura, Naoko
    Moriyama, Takahito
    Miyabe, Yoei
    Akiyama, Kenichi
    Karasawa, Kazunori
    Nitta, Kosaku
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2021, 32 (10): : 497 - 497
  • [10] Severity of arterial and/or arteriolar sclerosis in IgA nephropathy and the effects of renin-angiotensin system inhibitors on its prognosis
    Sugiura, Naoko
    Moriyama, Takahito
    Miyabe, Yoei
    Karasawa, Kazunori
    Nitta, Kosaku
    JOURNAL OF PATHOLOGY CLINICAL RESEARCH, 2021, 7 (06): : 616 - 623
12345